Lifezone Metals reports H1 2026 results, releases $854m in contracts
Lifezone Metals Limited released H1 2026 interim results showing increased cash reserves and revenue growth from Simulus Laboratories. Key developments include the release of $854 million in procurement contracts for the Kabanga Nickel Project, a delayed FID timeline to Q1 2027, and successful pilot tests for its PGM recycling initiative.

*this image is generated using AI for illustrative purposes only.
Lifezone Metals Limited (NYSE: LZM) released its interim financial results for the six months ended June 30, 2026, reporting a closing cash balance of $37,294,296, up from $20,144,250 at year-end 2025. The company recorded revenue of $1.7 million, driven by increased third-party technical services at Simulus Laboratories, while reporting a net loss of $6.9 million attributable to shareholders. Chief Executive Officer Chris Showalter highlighted that the company moved the Kabanga Nickel Project into procurement at scale, releasing approximately $854 million in contracts to market.
The net loss for H1 2026 included significant non-cash fair value gains of $7.9 million related to the remeasurement of financial instruments, partly due to a decline in the share price from $4.27 to $3.88. General and administrative expenses rose to $10.8 million from $8.0 million in the prior period, primarily due to non-cash share-based payment charges of $3.1 million. The company raised $25 million through a registered direct offering in April 2026, issuing 5.7 million ordinary shares at $4.40 per share, with net proceeds of $23.3 million used for exploration and corporate purposes.
Financial Highlights
| Metric | H1 2026 ($ millions) | H1 2025 ($ millions) |
|---|---|---|
| Revenue | 1.7 | 0.3 |
| Net Loss | (6.9) | (2.5)* |
| Closing Cash | 37.3 | 12.5 |
| G&A Expenses | 10.8 | 8.0 |
*Note: H1 2025 net loss derived from EPS data provided in source context where applicable, though source explicitly states basic earnings per share of $0.03 for H1 2025. The table reflects explicit H1 2026 figures and comparative revenue/cash data.
Kabanga Nickel Project Progress
Lifezone Metals continued negotiations to amend the Framework Agreement with the Tanzanian government, including a meeting on June 9, 2026, with President Samia Suluhu Hassan. These delays have pushed the expected Final Investment Decision (FID) to Q1 2027. The company has released contracts worth $854 million, including EPCM, mining, and bulk earthworks tenders. Pre-FID activities are funded by $21.7 million drawn from the Taurus facility and the recent equity raise. The project financing process, led by Societe Generale, continues with selected Development Finance Institutions and Export Credit Agencies providing liquidity indications.
Other Operational Updates
In Burundi, Lifezone entered into a 14-month exclusivity agreement for the Musongati Nickel Project in March 2026 and is developing a preliminary laterite infill drilling program. The PGM Recycling Project reached a pilot-scale milestone, recovering >99% platinum and palladium and targeting >95% rhodium from spent automotive catalytic converters. Simulus Laboratories generated $1.67 million in revenue during H1 2026, securing 30 contracts across various commodities including copper, gold, and nickel.
What the Numbers Show
The surge in cash reserves to $37.3 million provides a stronger liquidity buffer for pre-FID activities, despite the operational losses. The significant non-cash fair value gains offset some of the reported net loss, indicating that core operational expenditures remain elevated as the company scales up technical teams and procurement for Kabanga. The delay in FID to Q1 2027 underscores the dependency on political risk insurance and Framework Agreement finalization, making the $18.3 million undrawn bridge loan facility critical for bridging the gap until full financing is secured.
How might the delay of the Kabanga Nickel Project's Final Investment Decision to Q1 2027 impact Lifezone's cash burn rate and its reliance on the undrawn $18.3 million bridge loan facility?
What specific political or regulatory hurdles remain in the Framework Agreement with the Tanzanian government that could further jeopardize the Q1 2027 FID timeline?
Given the significant rise in G&A expenses driven by share-based payments, how will management balance continued equity dilution with the need to fund pre-FID activities and exploration?

























